Literature DB >> 30116136

Current treatment options for severe autoimmune hemolytic anemia.

Osman Yeşilbaş1.   

Abstract

Entities:  

Year:  2018        PMID： 30116136      PMCID： PMC6089784          DOI： 10.5152/TurkPediatriArs.2018.6499

Source DB:  PubMed          Journal:  Turk Pediatri Ars


× No keyword cloud information.
  5 in total

Review 1.  Current treatment strategies in autoimmune hemolytic disorders.

Authors:  Wilma Barcellini
Journal:  Expert Rev Hematol       Date:  2015-07-31       Impact factor: 2.929

Review 2.  Cold agglutinin disease.

Authors:  Sigbjørn Berentsen
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2016-12-02

3.  Benefits of rituximab as a second-line treatment for autoimmune haemolytic anaemia in children: a prospective French cohort study.

Authors:  Stéphane Ducassou; Guy Leverger; Helder Fernandes; Hervé Chambost; Yves Bertrand; Corinne Armari-Alla; Brigitte Nelken; Fabrice Monpoux; Corinne Guitton; Thierry Leblanc; Alain Fisher; Odile Lejars; Eric Jeziorski; Fanny Fouissac; Patrick Lutz; Marlène Pasquet; Isabelle Pellier; Christophe Piguet; Philippe Vic; Sophie Bayart; Aude Marie-Cardine; Marc Michel; Yves Perel; Nathalie Aladjidi
Journal:  Br J Haematol       Date:  2017-04-26       Impact factor: 6.998

Review 4.  Guidelines on the Use of Therapeutic Apheresis in Clinical Practice-Evidence-Based Approach from the Writing Committee of the American Society for Apheresis: The Seventh Special Issue.

Authors:  Joseph Schwartz; Anand Padmanabhan; Nicole Aqui; Rasheed A Balogun; Laura Connelly-Smith; Meghan Delaney; Nancy M Dunbar; Volker Witt; Yanyun Wu; Beth H Shaz
Journal:  J Clin Apher       Date:  2016-06       Impact factor: 2.821

5.  Plasmapheresis in a child with cold antibody autoimmune hemolytic anemia: case report.

Authors:  Zeynep Canan Özdemir; Özcan Bör; Ener Çağrı Dinleyici; Eylem Kıral
Journal:  Turk Pediatri Ars       Date:  2017-09-01
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.